Papers: 10.3390/biomedicines7010018

https://doi.org/10.3390/biomedicines7010018

Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis

Cited by: 30
Author(s): Stanley Cohan, Elisabeth B. Lucassen, Meghan Romba, Stefanie N. Linch
Published: over 6 years ago

Software Mentions 1